Guangdong Jiaying Pharmaceutical Co Ltd - Asset Resilience Ratio
Guangdong Jiaying Pharmaceutical Co Ltd (002198) has an Asset Resilience Ratio of 0.46% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Guangdong Jiaying Pharmaceutical Co Ltd (002198) strategic investment index to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2014–2025)
This chart shows how Guangdong Jiaying Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. See 002198 net asset quality score to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Guangdong Jiaying Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Guangdong Jiaying Pharmaceutical Co Ltd market cap and net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥4.10 Million | 0.46% |
| Total Liquid Assets | CN¥4.10 Million | 0.46% |
Asset Resilience Insights
- Limited Liquidity: Guangdong Jiaying Pharmaceutical Co Ltd maintains only 0.46% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Guangdong Jiaying Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio
Compare Guangdong Jiaying Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
AstraZeneca PLC
F:ZEGA |
Drug Manufacturers - General | 0.03% |
|
AstraZeneca PLC
NASDAQ:AZN |
Drug Manufacturers - General | 0.10% |
|
Novartis AG
SW:NOVN |
Drug Manufacturers - General | 0.08% |
|
Pfizer Inc
SA:PFIZ34 |
Drug Manufacturers - General | 5.48% |
|
Pfizer Inc
NYSE:PFE |
Drug Manufacturers - General | 5.48% |
|
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.
SHE:301096 |
Drug Manufacturers - General | 1.58% |
|
Hunan Jingfeng Pharmaceutical
SHE:000908 |
Drug Manufacturers - General | 0.38% |
|
Zhejiang Int'L Group Co Ltd
SHE:000411 |
Drug Manufacturers - General | 0.00% |
Annual Asset Resilience Ratio for Guangdong Jiaying Pharmaceutical Co Ltd (2014–2025)
The table below shows the annual Asset Resilience Ratio data for Guangdong Jiaying Pharmaceutical Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 1.47% | CN¥12.47 Million ≈ $1.82 Million |
CN¥849.23 Million ≈ $124.27 Million |
-22.19pp |
| 2023-12-31 | 23.66% | CN¥200.53 Million ≈ $29.34 Million |
CN¥847.56 Million ≈ $124.03 Million |
+17.72pp |
| 2022-12-31 | 5.94% | CN¥50.26 Million ≈ $7.35 Million |
CN¥846.65 Million ≈ $123.89 Million |
+11.94pp |
| 2019-12-31 | -6.00% | CN¥-51.35 Million ≈ $-7.51 Million |
CN¥855.94 Million ≈ $125.25 Million |
-6.00pp |
| 2018-12-31 | 0.00% | CN¥-12.83K ≈ $-1.88K |
CN¥889.56 Million ≈ $130.17 Million |
+0.04pp |
| 2017-12-31 | -0.04% | CN¥-326.08K ≈ $-47.72K |
CN¥876.61 Million ≈ $128.28 Million |
+0.38pp |
| 2016-12-31 | -0.42% | CN¥-4.58 Million ≈ $-670.90K |
CN¥1.10 Billion ≈ $160.86 Million |
-- |
| 2015-12-31 | 0.00% | CN¥0.00 ≈ $0.00 |
CN¥1.05 Billion ≈ $153.35 Million |
-- |
| 2014-12-31 | 0.00% | CN¥0.00 ≈ $0.00 |
CN¥1.04 Billion ≈ $151.49 Million |
-- |
About Guangdong Jiaying Pharmaceutical Co Ltd
Guangdong Jiaying Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese patent medicines in Mainland China. The company offers medicines primarily for the treatment of throat, cold, orthopedics, rheumatism, gynecology, heat-clearing, tonic, and gastrointestinal diseases. It also provides Shuangliao Houfeng powder, Chongganling tablets, Jiegu Qili tablet… Read more